Long-term colorectal-cancer mortality after adenoma removal lower than previously thought
8/29/2014
Patients with intestinal polyps have a lower risk of dying from cancer than previously thought, according to Norwegian researchers. The Norwegian study is the world's largest of its kind.
Leading scientists call for a stop to non-essential use of fluorochemicals
8/29/2014
A number of leading international researchers, amongst others from the National Food Institute, Technical University of Denmark, recommend that fluorochemicals are only used where they are absolutely...
Lexaptepid represents first potential treatment for common anemia
8/29/2014
An experimental drug designed to help regulate the blood's iron supply shows promise as a viable first treatment for anemia of inflammation, according to results from the first human study of the...
Acoustic device that separates tumor cells from blood cells could help assess cancer's spread
8/29/2014
Researchers from MIT, Pennsylvania State University, and Carnegie Mellon University have devised a new way to separate cells by exposing them to sound waves as they flow through a tiny channel.
Kit Lam and colleagues from UC Davis and other institutions have created dynamic nanoparticles (NPs) that could provide an arsenal of applications to diagnose and treat cancer.
Tomato-rich diet lowers prostate cancer risks
8/28/2014
Lycopene, an antioxidant abundant in tomatoes, could reduce cancer risks for men who consume over 10 portions a week, according to a new study.
Sound waves separate tumor and blood cells
8/28/2014
Tilted sound waves effectively separate different cell types without labeling or altering them, offering a new way to sort cells for research, disease diagnosis and drug testing.
GlaxoSmithKline plc has announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the once-daily use of Promacta® (eltrombopag) in...
They say knowledge is power, and a new UCLA study has shown this is definitely the case when it comes to men making the best decisions about how to treat their prostate cancer.
NewYork-Presbyterian/Columbia University Medical Center is finding new ways to use individualized, internal radiation delivered in the operating room immediately after a cancer tumor is removed.